Folate receptor β performs an immune checkpoint function in activated macrophages

Monocytes and macrophages are sentinels of the immune system that distinguish themselves from other cells by expressing the beta isoform of the folate receptor (FRβ). Because FRβ does not bind folate until the monocyte/macrophage is exposed to immunosuppressive cytokines, the question naturally aros...

Full description

Bibliographic Details
Published in:	Frontiers in Immunology
Main Authors:	Fenghua Zhang, Md Yusuf Al-Amin, Sagar Utturkar, Rina Jiang, Gregory Cresswell, Rami Alfar, Ian Ophaug-Johansen, Gabriel Bachman, Madduri Srinivasarao, Richard Finnell, Amaya Puig-Kröger, Timothy Ratliff, Philip S. Low
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-09-01
Subjects:	immune checkpoint macrophages MDSCs (myeloid-derived suppressor cells) folate receptor beta (FRβ, Folr2) tumor-associated macrophages (TAMs) tumor microenvironment
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1638907/full

Similar Items

Radiation dosimetry of 18F-AzaFol: A first in-human use of a folate receptor PET tracer
by: Silvano Gnesin, et al.
Published: (2020-04-01)

Tumor-specific activation of folate receptor beta enables reprogramming of immune cells in the tumor microenvironment
by: Fenghua Zhang, et al.
Published: (2024-02-01)

A Case of Cerebral Folate Deficiency due to FOLR1 Mutation in a 10‐Year‐Old Girl: Clinical Presentation and Treatment Outcomes
by: Farzad Ahmadabadi, et al.
Published: (2025-10-01)

Folate Receptor β (FRβ) Expression in Tissue-Resident and Tumor-Associated Macrophages Associates with and Depends on the Expression of PU.1
by: Rafael Samaniego, et al.
Published: (2020-06-01)

Pharmacoresistant Epilepsy in Childhood: Think of the Cerebral Folate Deficiency, a Treatable Disease
by: Sarah Mafi, et al.
Published: (2020-10-01)

The role of folate receptor and reduced folate carrier polymorphisms in osteoporosis development
by: Mrozikiewicz Aleksandra E., et al.
Published: (2019-06-01)

Therapeutic strategies targeting folate receptor α for ovarian cancer
by: Jia Mai, et al.
Published: (2023-08-01)

Cerebral folate deficiency: A report of two affected siblings
by: Rabah Almahmoud, et al.
Published: (2023-06-01)

Corrigendum: Therapeutic strategies targeting folate receptor α for ovarian cancer
by: Jia Mai, et al.
Published: (2024-04-01)

Case Report: Cerebral folate deficiency caused by FOLR1 variant
by: Qian Wang, et al.
Published: (2024-09-01)

Selective reprogramming of regulatory T cells in solid tumors can strongly enhance or inhibit tumor growth
by: Rami Alfar, et al.
Published: (2023-10-01)

A Clinical and Genetic Evaluation of Cases with Folate Receptor α Gene Mutation: A Case Series from Türkiye
by: Abdurrahman Akgun, et al.
Published: (2025-04-01)

Folate Receptor Beta Signaling in the Regulation of Macrophage Antimicrobial Immune Response: A Scoping Review
by: Anna C.C. Castelo Branco, et al.
Published: (2024-02-01)

Key players of immunosuppression in epithelial malignancies: Tumor‐infiltrating myeloid cells and γδ T cells
by: Baishali Tamuli, et al.
Published: (2024-05-01)

Ferumoxytol Attenuates the Function of MDSCs to Ameliorate LPS-Induced Immunosuppression in Sepsis
by: Yujun Xu, et al.
Published: (2019-12-01)

FOLR2+ macrophages in cancer: allies or enemies
by: Decheng Jiang, et al.
Published: (2025-06-01)

Tissue distribution and tumor uptake of folate receptor–targeted epothilone folate conjugate, BMS-753493, in CD2F1 mice after systemic administration
by: Hong Shen, et al.
Published: (2016-09-01)

<i>KDM6B</i> Variants May Contribute to the Pathophysiology of Human Cerebral Folate Deficiency
by: Xiao Han, et al.
Published: (2022-12-01)

A Novel Treatment for Glomerular Disease: Targeting the Activated Macrophage Folate Receptor with a Trojan Horse Therapy in Rats
by: Gabriela E. Garcia, et al.
Published: (2021-08-01)

Design of Folate-Containing Liposomal Nucleic Acid Delivery Systems for Antitumor Therapy
by: Elena V. Shmendel, et al.
Published: (2023-05-01)

Immunosuppression in Sepsis: Biomarkers and Specialized Pro-Resolving Mediators
by: Cristina M. Padovani, et al.
Published: (2024-01-01)

Clinical significance of postoperative folate receptor‐positive circulating tumor cells (FR + CTCs) for long‐term prognosis in patients with invasive adenocarcinoma (IAC) of the lung
by: Zeming Ma, et al.
Published: (2024-05-01)

Folate receptor 1 is a stemness trait-associated diagnostic and prognostic marker for hepatocellular carcinoma
by: Yuto Shiode, et al.
Published: (2025-03-01)

Folate receptor-targeted positron emission tomography of experimental autoimmune encephalomyelitis in rats
by: Petri Elo, et al.
Published: (2019-12-01)

Folate receptor alpha for cancer therapy: an antibody and antibody-drug conjugate target coming of age
by: Yi Liu, et al.
Published: (2025-12-01)

Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes
by: Milena Kalaitsidou, et al.
Published: (2023-11-01)

Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy
by: Yi Wang, et al.
Published: (2022-08-01)

Progress of research on the relationship between efferocytosis and tumor
by: Xuexin Yao, et al.
Published: (2024-04-01)

Can Nuclear Imaging of Activated Macrophages with Folic Acid-Based Radiotracers Serve as a Prognostic Means to Identify COVID-19 Patients at Risk?
by: Cristina Müller, et al.
Published: (2020-09-01)

Targeting folate cycle enhances effects of cancer immunotherapy by modulating myeloid-derived suppressor cells
by: HE Rui, et al.
Published: (2024-08-01)

Noncoding RNA-Mediated Regulation of Myeloid-Derived Suppressor Cells in Cancer
by: Luo K, et al.
Published: (2025-10-01)

Macrophage barrier in the tumor microenvironment and potential clinical applications
by: Shuai Ji, et al.
Published: (2024-01-01)

Evaluation of Folate-Functionalized Nanoparticle Drug Delivery Systems—Effectiveness and Concerns
by: Muhammad Aiman Irfan Ibrahim, et al.
Published: (2023-07-01)

Sorafenib enhanced the function of myeloid-derived suppressor cells in hepatocellular carcinoma by facilitating PPARα-mediated fatty acid oxidation
by: Chunxiao Li, et al.
Published: (2025-01-01)

The Roles and Targeting of Tumor-Associated Macrophages
by: Yuqian Li, et al.
Published: (2023-09-01)

Metabolic Cancer-Macrophage Crosstalk in the Tumor Microenvironment
by: Kyra E. de Goede, et al.
Published: (2020-11-01)

Tumor-Associated Macrophages: Recent Insights and Therapies
by: Jiawei Zhou, et al.
Published: (2020-02-01)

Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis
by: Fenghua Zhang, et al.
Published: (2020-06-01)

Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer
by: Qian Zhou, et al.
Published: (2021-12-01)

Stabilin-1 in Tumor-Associated Macrophages: A Potential Therapeutic Target in Cancer Immunotherapy
by: Jampa Lhamo Gurung, et al.
Published: (2025-09-01)